#$%^&*AU2013202865B220150319.pdf#####H:\aar\lioenoven\NRPoribi\DCC\AAR\505385_ 1.DOC-8/04/2013 26b ABSTRACT The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolipids and antigen. The said compounds are also able to target drug to CD1d restricted cells.